Clinical trial
Haploidentical Hematopoietic Stem Cell Transplantation Patients With…
NCT00160355 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00160355 |
|---|---|
| Title | Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome |
| Official title | Haploidentical Hematopoietic Stem Cell Transplantation for Pediatric Patients With Wiskott-Aldrich Syndrome: A Pilot Study |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Wiskott-Aldrich Syndrome |
| Intervention type | Device, Drug, Procedure |
| Interventions | Hematopoietic stem cell transplantation, Miltenyi CliniMACS selection system, Fludarabine, Melphalan, Thiotepa |
| Enrollment | 4 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: